The effect of probiotic use on fasting glycemia, insulin resistance and glycated hemoglobin in people with type 2 Diabetes mellitus: a literature review

Detalhes bibliográficos
Autor(a) principal: Souza, Mariana Pimentel Gomes
Data de Publicação: 2022
Outros Autores: Mendes, Renata Cristina Machado, Reis, Dayanna Magalhães dos, Martins, Maria Yasmin Paz Teixeira
Tipo de documento: Artigo
Idioma: por
Título da fonte: Research, Society and Development
Texto Completo: https://rsdjournal.org/index.php/rsd/article/view/27972
Resumo: The aim of this study is to summarize the evidence in the literature about the effect of probiotics on glycemic control in patients with type 2 diabetes mellitus (T2DM). This is an integrative literature review to answer the question: “What is the evidence on the use of probiotics to reduce fasting glucose and/or glycated hemoglobin and/or insulin resistance in people with T2DM”. The search was performed in the Medline-PubMed, Cochrane Library and Bireme databases using descriptors combined using the OR and AND operators. Randomized clinical trials performed with adult humans diagnosed with T2DM and which evaluated at least one of the outcomes of interest were included. The search resulted in 207 articles, of which 14 were included. The duration of the intervention ranged from 6 weeks to 6 months, the number of strains from 1 to 14, the daily dose from 106 to 1010 CFU. Most studies included Lactobacillus and Bifidobacterium. The species and strains that appeared the most were Lactobacillus acidophilus, Lactobacillus casei, Bifidobacterium lactis and Streptococcus Thermophilus. It is suggested that the use of probiotics may be a strategy for managing T2DM, as most studies have shown a positive effect on at least one of the parameters.
id UNIFEI_e051d8b0f713fd670bfb189a69210e6d
oai_identifier_str oai:ojs.pkp.sfu.ca:article/27972
network_acronym_str UNIFEI
network_name_str Research, Society and Development
repository_id_str
spelling The effect of probiotic use on fasting glycemia, insulin resistance and glycated hemoglobin in people with type 2 Diabetes mellitus: a literature reviewEl efecto del uso de probióticos sobre la glucemia en ayunas, la resistencia a la insulina y la hemoglobina glicada en personas con Diabetes mellitus tipo 2: una revisión de la literaturaO efeito do uso de probióticos sobre glicemia de jejum, resistência à insulina e hemoglobina glicada em pessoas com Diabetes mellitus tipo 2: uma revisão de literaturaProbióticosDiabetes Mellitus Tipo 2Glucosa en sangreResistencia a la insulinaHemoglobina glicosilada.ProbióticosDiabetes Mellitus Tipo 2GlicemiaResistência à insulinaHemoglobina glicada.ProbioticsType 2 Diabetes MellitusBlood glucoseInsulin resistanceGlycated hemoglobin A. The aim of this study is to summarize the evidence in the literature about the effect of probiotics on glycemic control in patients with type 2 diabetes mellitus (T2DM). This is an integrative literature review to answer the question: “What is the evidence on the use of probiotics to reduce fasting glucose and/or glycated hemoglobin and/or insulin resistance in people with T2DM”. The search was performed in the Medline-PubMed, Cochrane Library and Bireme databases using descriptors combined using the OR and AND operators. Randomized clinical trials performed with adult humans diagnosed with T2DM and which evaluated at least one of the outcomes of interest were included. The search resulted in 207 articles, of which 14 were included. The duration of the intervention ranged from 6 weeks to 6 months, the number of strains from 1 to 14, the daily dose from 106 to 1010 CFU. Most studies included Lactobacillus and Bifidobacterium. The species and strains that appeared the most were Lactobacillus acidophilus, Lactobacillus casei, Bifidobacterium lactis and Streptococcus Thermophilus. It is suggested that the use of probiotics may be a strategy for managing T2DM, as most studies have shown a positive effect on at least one of the parameters.El objetivo de este estudio es resumir la evidencia en la literatura sobre el efecto de los probióticos en el control glucémico en pacientes con DM2. Esta es una revisión integrativa de la literatura para responder a la pregunta: “¿Cuál es la evidencia sobre el uso de probióticos para reducir la glucosa en ayunas y/o la hemoglobina glicosilada y/o la resistencia a la insulina en personas con DM2”. La búsqueda se realizó en las bases de datos Medline-PubMed, Cochrane Library y Bireme utilizando descriptores combinados mediante los operadores OR y AND. Se incluyeron ensayos clínicos aleatorizados realizados con humanos adultos diagnosticados de DM2 y que evaluaran al menos uno de los desenlaces de interés. La búsqueda resultó en 207 artículos, de los cuales se incluyeron 14. La duración de la intervención varió de 6 semanas a 6 meses, el número de cepas de 1 a 14, la dosis diaria de 106 a 1010 UFC. La mayoría de los estudios incluyeron Lactobacillus y Bifidobacterium. Las especies y cepas que más aparecieron fueron Lactobacillus acidophilus, Lactobacillus casei, Bifidobacterium lactis y Streptococcus Thermophilus. Se sugiere que el uso de probióticos puede ser una estrategia para el manejo de la DM2, ya que la mayoría de los estudios han demostrado un efecto positivo en al menos uno de los parámetros.O objetivo desse estudo é sumarizar as evidências da literatura acerca do efeito dos probióticos sobre o controle glicêmico em pacientes com diabetes mellitus tipo 2. Trata-se de uma revisão integrativa da literatura para responder à pergunta: “Quais as evidências sobre o uso de probióticos na redução de glicemia de jejum e/ou hemoglobina glicada e/ou resistência à insulina em pessoas com DM2”. A busca foi realizada nas bases de dados Medline-PubMed, Cochrane Library e Bireme por meio de descritores combinados a partir dos operadores OR e AND. Incluiu-se ensaios clínicos randomizados realizados com humanos adultos com diagnóstico de DM2 e que avaliaram pelo menos um dos desfechos de interesse. A busca resultou em 207 artigos, dos quais 14 foram incluídos. A duração da intervenção variou de 6 semanas a 6 meses, o número de cepas de 1 a 14, a dose de diária de 106 a 1010 UFC. A maioria dos estudos incluiu Lactobacillus e Bifidobacterium. As espécies e cepas que mais apareceram foram Lactobacillus acidophilus, Lactobacillus casei, Bifidobacterium lactis e Streptococcus Thermophilus. Sugere-se que o uso de probióticos possa ser uma estratégia para manejo do DM2, pois a maioria dos estudos revelou efeito positivo sobre pelo menos um dos parâmetros.Research, Society and Development2022-03-30info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://rsdjournal.org/index.php/rsd/article/view/2797210.33448/rsd-v11i5.27972Research, Society and Development; Vol. 11 No. 5; e10411527972Research, Society and Development; Vol. 11 Núm. 5; e10411527972Research, Society and Development; v. 11 n. 5; e104115279722525-3409reponame:Research, Society and Developmentinstname:Universidade Federal de Itajubá (UNIFEI)instacron:UNIFEIporhttps://rsdjournal.org/index.php/rsd/article/view/27972/24369Copyright (c) 2022 Mariana Pimentel Gomes Souza; Renata Cristina Machado Mendes; Dayanna Magalhães dos Reis; Maria Yasmin Paz Teixeira Martinshttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessSouza, Mariana Pimentel GomesMendes, Renata Cristina Machado Reis, Dayanna Magalhães dosMartins, Maria Yasmin Paz Teixeira2022-04-17T18:18:56Zoai:ojs.pkp.sfu.ca:article/27972Revistahttps://rsdjournal.org/index.php/rsd/indexPUBhttps://rsdjournal.org/index.php/rsd/oairsd.articles@gmail.com2525-34092525-3409opendoar:2024-01-17T09:45:32.291489Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)false
dc.title.none.fl_str_mv The effect of probiotic use on fasting glycemia, insulin resistance and glycated hemoglobin in people with type 2 Diabetes mellitus: a literature review
El efecto del uso de probióticos sobre la glucemia en ayunas, la resistencia a la insulina y la hemoglobina glicada en personas con Diabetes mellitus tipo 2: una revisión de la literatura
O efeito do uso de probióticos sobre glicemia de jejum, resistência à insulina e hemoglobina glicada em pessoas com Diabetes mellitus tipo 2: uma revisão de literatura
title The effect of probiotic use on fasting glycemia, insulin resistance and glycated hemoglobin in people with type 2 Diabetes mellitus: a literature review
spellingShingle The effect of probiotic use on fasting glycemia, insulin resistance and glycated hemoglobin in people with type 2 Diabetes mellitus: a literature review
Souza, Mariana Pimentel Gomes
Probióticos
Diabetes Mellitus Tipo 2
Glucosa en sangre
Resistencia a la insulina
Hemoglobina glicosilada.
Probióticos
Diabetes Mellitus Tipo 2
Glicemia
Resistência à insulina
Hemoglobina glicada.
Probiotics
Type 2 Diabetes Mellitus
Blood glucose
Insulin resistance
Glycated hemoglobin A.
title_short The effect of probiotic use on fasting glycemia, insulin resistance and glycated hemoglobin in people with type 2 Diabetes mellitus: a literature review
title_full The effect of probiotic use on fasting glycemia, insulin resistance and glycated hemoglobin in people with type 2 Diabetes mellitus: a literature review
title_fullStr The effect of probiotic use on fasting glycemia, insulin resistance and glycated hemoglobin in people with type 2 Diabetes mellitus: a literature review
title_full_unstemmed The effect of probiotic use on fasting glycemia, insulin resistance and glycated hemoglobin in people with type 2 Diabetes mellitus: a literature review
title_sort The effect of probiotic use on fasting glycemia, insulin resistance and glycated hemoglobin in people with type 2 Diabetes mellitus: a literature review
author Souza, Mariana Pimentel Gomes
author_facet Souza, Mariana Pimentel Gomes
Mendes, Renata Cristina Machado
Reis, Dayanna Magalhães dos
Martins, Maria Yasmin Paz Teixeira
author_role author
author2 Mendes, Renata Cristina Machado
Reis, Dayanna Magalhães dos
Martins, Maria Yasmin Paz Teixeira
author2_role author
author
author
dc.contributor.author.fl_str_mv Souza, Mariana Pimentel Gomes
Mendes, Renata Cristina Machado
Reis, Dayanna Magalhães dos
Martins, Maria Yasmin Paz Teixeira
dc.subject.por.fl_str_mv Probióticos
Diabetes Mellitus Tipo 2
Glucosa en sangre
Resistencia a la insulina
Hemoglobina glicosilada.
Probióticos
Diabetes Mellitus Tipo 2
Glicemia
Resistência à insulina
Hemoglobina glicada.
Probiotics
Type 2 Diabetes Mellitus
Blood glucose
Insulin resistance
Glycated hemoglobin A.
topic Probióticos
Diabetes Mellitus Tipo 2
Glucosa en sangre
Resistencia a la insulina
Hemoglobina glicosilada.
Probióticos
Diabetes Mellitus Tipo 2
Glicemia
Resistência à insulina
Hemoglobina glicada.
Probiotics
Type 2 Diabetes Mellitus
Blood glucose
Insulin resistance
Glycated hemoglobin A.
description The aim of this study is to summarize the evidence in the literature about the effect of probiotics on glycemic control in patients with type 2 diabetes mellitus (T2DM). This is an integrative literature review to answer the question: “What is the evidence on the use of probiotics to reduce fasting glucose and/or glycated hemoglobin and/or insulin resistance in people with T2DM”. The search was performed in the Medline-PubMed, Cochrane Library and Bireme databases using descriptors combined using the OR and AND operators. Randomized clinical trials performed with adult humans diagnosed with T2DM and which evaluated at least one of the outcomes of interest were included. The search resulted in 207 articles, of which 14 were included. The duration of the intervention ranged from 6 weeks to 6 months, the number of strains from 1 to 14, the daily dose from 106 to 1010 CFU. Most studies included Lactobacillus and Bifidobacterium. The species and strains that appeared the most were Lactobacillus acidophilus, Lactobacillus casei, Bifidobacterium lactis and Streptococcus Thermophilus. It is suggested that the use of probiotics may be a strategy for managing T2DM, as most studies have shown a positive effect on at least one of the parameters.
publishDate 2022
dc.date.none.fl_str_mv 2022-03-30
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://rsdjournal.org/index.php/rsd/article/view/27972
10.33448/rsd-v11i5.27972
url https://rsdjournal.org/index.php/rsd/article/view/27972
identifier_str_mv 10.33448/rsd-v11i5.27972
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://rsdjournal.org/index.php/rsd/article/view/27972/24369
dc.rights.driver.fl_str_mv https://creativecommons.org/licenses/by/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Research, Society and Development
publisher.none.fl_str_mv Research, Society and Development
dc.source.none.fl_str_mv Research, Society and Development; Vol. 11 No. 5; e10411527972
Research, Society and Development; Vol. 11 Núm. 5; e10411527972
Research, Society and Development; v. 11 n. 5; e10411527972
2525-3409
reponame:Research, Society and Development
instname:Universidade Federal de Itajubá (UNIFEI)
instacron:UNIFEI
instname_str Universidade Federal de Itajubá (UNIFEI)
instacron_str UNIFEI
institution UNIFEI
reponame_str Research, Society and Development
collection Research, Society and Development
repository.name.fl_str_mv Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)
repository.mail.fl_str_mv rsd.articles@gmail.com
_version_ 1797052764459630592